Cervical cancer

Benjamin E. Greer*, Wui Jin Koh, Nadeem R. Abu-Rustum, Michael A. Bookman, Robert E. Bristow, Susana Campos, Kathleen R. Cho, Larry Copeland, Patricia Eifel, Warner K. Huh, Wainwright Jaggernauth, Daniel S. Kapp, John Kavanagh, Gary H. Lipscomb, John R. Lurain, Mark Morgan, Robert J. Morgan, C. Bethan Powell, Steven W. Remmenga, R. Kevin ReynoldsAngeles Alvarez Secord, William Small, Nelson Teng

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations


Although cervical cancer is decreasing in the United States, because screening is widely used, it is increasing in developing countries (approximately 270,000 deaths per year), because screening is not available to many women. Effective treatment for cervical cancer (e.g., surgery, concurrent chemoradiation) can yield cures in 80% of women with early-stage disease (stages I and II) and in 60% with stage III disease. The hope is that immunization against HPV (using the new vaccines) will prevent persistent infection with certain types of HPV, and is therefore expected to prevent specific HPV cancer in women.9,69

Original languageEnglish (US)
Pages (from-to)14-36
Number of pages23
JournalJNCCN Journal of the National Comprehensive Cancer Network
Issue number1
StatePublished - Jan 2008


  • Cervical cancer
  • Chemotherapy
  • Human papillomavirus
  • Hysterectomy
  • NCCN clinical practice guidelines
  • Radiation therapy

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Cervical cancer'. Together they form a unique fingerprint.

Cite this